[1]Wang Z,Wang H,Ma B,et al.Efficacy and safety of anti-epidermal growth factor receptor therapy compared with anti-vascular endothelial growth factor therapy for metastatic colorectal cancer in first-line and second-line therapies:a meta-analysis[J].Onco Targets Ther,2016,32(9):5405-5416.
[2]Azzariti A,Porcelli L,Brunetti O,et al.Total and not bevacizumab-bound vascular endothelial growth factor as potential predictive factors to bevacizumab-based chemotherapy in colorectal cancer[J].World J Gastroenterol,2016,22(27):6287-6289.
[3]Zhou Q,Zhu Y,Wei X,et al.MiR-590-5p inhibits colorectal cancer angiogenesis and metastasis by regulating nuclear factor 90/vascular endothelial growth factor A axis[J].Cell Death Dis,2016,7(10):2413-2416.
[4]王益,张晶,刘蓓.血管表皮生长因子对大肠癌细胞生长的影响机制研究[J].实用癌症杂志,2016,31(05):737-739.
[5]刘志,赵春清,张彬,等.VEGF、Bmi-1在结肠癌组织中的表达及意义[J].河北医药,2016,38(20):3104-3106.
[6]骆礼波,程家平,杨伟明,等.vegf和MVD在大肠癌中的表达及预后意义[J].遵义医学院学报,2013,36(6):546-549.
[7]谭丽珊.结直肠癌中CXCR7、vegf、Ki-67和PTEN表达[J].广东医学院学报,2014,32(3):295-297.
[8]张泽进,张东卫,谭莹.结肠癌VEGF-C表达与淋巴管生成、淋巴结转移的关系[J].中华全科医学,2013(06):867-869. |
2017, Vol. 34 
